新西兰 - 英文 - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - amoxicillin sodium 530.1mg equivalent to amoxicillin 500 mg;  ; potassium clavulanate 119.13mg equivalent to clavulanic acid 100 mg;  ;  ;   - powder for injection - 600 mg - active: amoxicillin sodium 530.1mg equivalent to amoxicillin 500 mg   potassium clavulanate 119.13mg equivalent to clavulanic acid 100 mg       - augmentin is indicated for the short term treatment of common bacterial infections such as: -upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media -lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia -genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections -skin and soft tissue infections -bone and joint infections: e.g. osteomyelitis -other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis, post-surgical infections augmentin is indicated for prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery.

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

morgan and hall ltd - disodium edetate dihydrate 0.01%{relative}; miranol 2mca 0.2%{relative}; thiomersal 0.004%{relative} - contact lens solution - 0.01%/0.2%/0.004% - active: disodium edetate dihydrate 0.01%{relative} miranol 2mca 0.2%{relative} thiomersal 0.004%{relative}

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - flucloxacillin sodium monohydrate 1088mg equivalent to 1000 mg flucloxacillin free acid;  ;   - powder for injection - 1 g - active: flucloxacillin sodium monohydrate 1088mg equivalent to 1000 mg flucloxacillin free acid    

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - flucloxacillin sodium monohydrate 272mg equivalent to 250 mg flucloxacillin free acid;  ;   - powder for injection - 250 mg - active: flucloxacillin sodium monohydrate 272mg equivalent to 250 mg flucloxacillin free acid    

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - flucloxacillin sodium monohydrate 544mg equivalent to 500 mg flucloxacillin free acid;  ;   - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 544mg equivalent to 500 mg flucloxacillin free acid    

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - flucloxacillin sodium monohydrate 500mg - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 500mg

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

origen pharmaceuticals limited - flucloxacillin sodium monohydrate 25 mg/ml equivalent to flucloxacillin 25 mg/ml;   - powder for oral suspension - 125 mg/5ml - active: flucloxacillin sodium monohydrate 25 mg/ml equivalent to flucloxacillin 25 mg/ml  

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

hospira nz ltd - flucloxacillin sodium monohydrate 262.1mg equivalent to 250 mg flucloxicillin;   - powder for injection - 250 mg - active: flucloxacillin sodium monohydrate 262.1mg equivalent to 250 mg flucloxicillin  

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

hospira nz ltd - flucloxacillin sodium monohydrate 524.2mg equivalent to 500 mg flucloxicillin.;   - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 524.2mg equivalent to 500 mg flucloxicillin.  

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - flucloxacillin sodium monohydrate 26.26 mg/ml equivalent to flucloxacillin 25 mg/ml - powder for syrup - 125 mg/5ml - active: flucloxacillin sodium monohydrate 26.26 mg/ml equivalent to flucloxacillin 25 mg/ml excipient: strawberry raspberry mint saccharin sodium silicic acid sodium citrate dihydrate sucrose sunset yellow fcf water